SCHEMBL23891925

SCHEMBL23891925

C=C(N)Cc1ccc(CN)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABAT P80404 1/20 0.50
LOXL2 Q9Y4K0 6/20 0.48
F10 P00742 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
NOS3 P29474 2/20 0.45
NOS1 P29475 2/20 0.45
NOS2 P35228 2/20 0.45
F11 P03951 1/20 0.43
TAAR1 Q96RJ0 1/20 0.41
TPSAB1 Q15661 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
CA2 P00918 2/20 0.38
ENPP2 Q13822 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9256936 0.80 ALDH1A1 (0.48) LOXL2NOS1CA2CA6CA14
SCHEMBL10535299 0.80 CA2 (0.60) ABATTAAR1CA2
SCHEMBL22548657 0.79 TAAR1 (0.52) LOXL2HRH3TAAR1ENPP2
SCHEMBL13069072 0.78 LOXL2 (0.48) LOXL2TAAR1
SCHEMBL24386036 0.78 IDO1 (0.47) TAAR1CA2
SCHEMBL12942979 0.78 IDO1 (0.47) TAAR1
SCHEMBL23892032 0.78 NOS1 (0.48) ABATLOXL2F10HRH3NOS3
SCHEMBL8033735 0.78 CA2 (0.37) NOS1CA2
SCHEMBL4958170 0.77 CES1 (0.50) LOXL2NOS3NOS1NOS2HDAC6
SCHEMBL2700841 0.75 LOXL2 (0.60) ABATLOXL2F10HRH3NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed
EP-3177611-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2021-10-06 EP disclosed